🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open-label, multicenter, first-in-human, Phase I, dose esc...
Status
Completed
Location
Breast Cancer Research Centre
Start Date
2022-09-02
Trial ID
NCT05494918
Treatments Being Tested
Our study is aimed to evaluate the efficacy and safety of novel ADC named S...
Status
Unknown
Location
Fudan Cancer Hospital
Start Date
2024-12
Trial ID
NCT06470672
Treatments Being Tested
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
This study aims to evaluate the efficacy and safety of U3-1402 in participa...
Status
Recruiting
Location
Centre Georges François Leclerc
Start Date
2021-05-11
Trial ID
NCT04965766
Treatments Being Tested
In phase Ib, our study is aimed to evaluate the safety and tolerance of SHR...
Status
Recruiting
Location
Fudan Cancer Hospital
Start Date
2025-01-08
Trial ID
NCT06718933
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is an open-label, single-arm, Phase Ib/II investigator-initiated trial...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-02-15
Trial ID
NCT04264936
Treatments Being Tested
RATIONALE: Patients with HER2-negative advanced breast cancer have limited ...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2023-11-01
Trial ID
NCT06121557
Breast cancer is one of the most common malignancies in women worldwide, wi...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-04
Trial ID
NCT06492447
Treatments Being Tested
In this study, 60 patients with HER2 overexpression UTUC with high-risk rec...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2024-02-20
Trial ID
NCT06210490
Treatments Being Tested